logo
Q&A With Hunter Dean: ASEA's REDOXGold™ And The Future Of Redox Science

Q&A With Hunter Dean: ASEA's REDOXGold™ And The Future Of Redox Science

ASEA's REDOXGold™ Massage + Soothing Gel marks a pivotal shift in how individuals manage their recovery. Unlike traditional creams that temporarily mask discomfort, REDOXGold taps into the science of redox signaling to help soothing and recovery. As ASEA celebrates its 15th anniversary, the company extends its legacy of science-backed wellness to a broader global audience. Hunter Dean, Senior Vice President of R&D and Production Operations at ASEA, shares the rationale behind the product and what it means for people seeking a natural, sustainable approach to recovery. Recovery, Reimagined
Q: REDOXGold launched earlier this year and has already seen global expansion. What makes this product fundamentally different from other topical recovery solutions?
Hunter Dean: Most topical recovery products are designed to create a temporary effect—either warming the skin, or just cooling it, to distract from discomfort. REDOXGold does not rely on these traditional mechanisms. Instead, it works by delivering redox signaling molecules directly to the skin. These molecules are naturally produced by the human body and play a critical role in cellular communication. This intercellular communication is important. Over time, our natural production of these molecules declines. What REDOXGold does is provide an added boost of these redox signalling molecules to the skin to support the body's ability to restore communication pathways, so it can respond more efficiently to physical exertion. We also included real, elemental gold in the formula.
This is not just a product to make you feel better for an hour. It helps promote recovery where it actually starts—inside the cell.
Q: Redox signaling sounds technical. How can consumers understand its real-life relevance to wellness and performance?
Hunter Dean: Redox signaling is a basic process, even though the term may seem complex. It is how cells coordinate action to maintain resilience against environmental stress. Imagine a construction site without any communication between workers. Nothing would happen efficiently, and there would be chaos. That is what happens when redox signaling breaks down in the body. Muscles stay inflamed longer, recovery slows, and the effects of stress accumulate. REDOXGold supplies these molecules topically to the skin, reinforcing the body's own levels of redox signalling molecules. It is a very targeted and biological solution that respects how the body operates. That is what makes it different from chemically based products that simply override symptoms. Built for Real-World Use
Q: ASEA is known for ingestible products like the REDOX Cell Signaling Supplement. Why develop a topical gel for this particular release?
Hunter Dean: We wanted to give people a tool that fits into their everyday routines with minimal friction. A topical gel allows users to apply it precisely where they feel discomfort—whether that is a tired lower back, tight calves after a run, or shoulders after a long workday. There is an immediacy in applying something directly to the affected area, and that is what people are often looking for. At the same time, we knew that many consumers want a product that feels clean—no sticky residue, no heavy chemical scent, no artificial coloring. REDOXGold delivers all that. It absorbs quickly, does not stain clothes, and feels comfortable on the skin. We designed it for people who live active lives and want support that works with their natural rhythms and routines. It is not just a product for elite athletes. It is for anyone who values mobility and wants to feel physically capable.
Q: Who is the intended user? Are you primarily targeting athletes, or is this for a broader group?
Hunter Dean:While athletes have naturally gravitated toward REDOXGold, we created it for a much wider audience. We often refer to "Taylor," a profile that represents many of our consumers. Taylor might be someone who exercises regularly, hikes on weekends, or simply wants to feel less tension after a long day at work. Taylor prefers natural ingredients, reads labels, and avoids harsh treatments when possible. For this person, REDOXGold becomes a trusted solution. Older adults are also turning to it because they want to maintain their lifestyle and avoid feeling limited by temporary soreness. So whether someone is doing yoga, chasing after grandchildren, or preparing for a marathon, the product supports them in staying active without compromising their values or routine. Global Reach and Long-Term Vision
Q: The product launched in February 2025. How has it performed internationally in such a short time?
Hunter Dean: The reception has been incredibly positive, and the pace of adoption has exceeded our expectations. We launched initially in North America and Australasia—markets like the United States, Canada, Mexico, Australia, and New Zealand. By March, we expanded into 30 more countries, including major European markets such as France, Germany, Sweden, and the United Kingdom. This rapid growth was made possible by a multi-channel strategy. Our global network of independent associates played a key role in introducing the product to communities, while digital platforms helped drive awareness and online sales. We also focused on accessibility. Sample tubes allowed people to try the product before committing to full-size units, which helped generate interest and user feedback very early on.
Q: What kind of feedback have you received from users?
Hunter Dean: Users are telling us they experience quicker recovery after regular physical activity. We hear stories from people who had difficulty completing their daily walks or fitness routines and are now doing so with greater ease. Some older customers have shared that feel empowered and are more confident. That kind of feedback affirms what we learned prior to REDOXGold's launch with our global research university partners. It tells us that the science is not only sound, but meaningful to the people using it. That is ultimately what we care about—whether it is making a real difference in someone's quality of life.
Q: Does REDOXGold signal the beginning of a broader product expansion using redox technology?
Hunter Dean: Yes, it certainly does. REDOXGold is an important step forward, but it is far from the end of our work. We are continuing to explore new ways to apply redox principles across various formats. Some of these will be topical like REDOXGold, while others will be ingestible or possibly even delivered through emerging technologies. At the same time, we are refining our existing offerings based on the latest research and consumer insights. Everything we do is grounded in our long-term vision—helping people live fuller, more active lives through cellular health. We are not just adding products for the sake of variety. Each one must meet a real need and stay aligned with the science that defines ASEA.
REDOXGold signals a practical shift in how people recover from physical exertion. Rather than offering a surface-level fix, it supports the body's natural repair systems at the source. As Hunter Dean puts it, "This is not about masking sensations—it is about helping the body do what it is already capable of, more efficiently and with less limitation."
Explore more at: https://www. https://www.aseaglobal.com/en-US/redox-gold
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Q&A With Hunter Dean: ASEA's REDOXGold™ And The Future Of Redox Science
Q&A With Hunter Dean: ASEA's REDOXGold™ And The Future Of Redox Science

Int'l Business Times

time01-07-2025

  • Int'l Business Times

Q&A With Hunter Dean: ASEA's REDOXGold™ And The Future Of Redox Science

ASEA's REDOXGold™ Massage + Soothing Gel marks a pivotal shift in how individuals manage their recovery. Unlike traditional creams that temporarily mask discomfort, REDOXGold taps into the science of redox signaling to help soothing and recovery. As ASEA celebrates its 15th anniversary, the company extends its legacy of science-backed wellness to a broader global audience. Hunter Dean, Senior Vice President of R&D and Production Operations at ASEA, shares the rationale behind the product and what it means for people seeking a natural, sustainable approach to recovery. Recovery, Reimagined Q: REDOXGold launched earlier this year and has already seen global expansion. What makes this product fundamentally different from other topical recovery solutions? Hunter Dean: Most topical recovery products are designed to create a temporary effect—either warming the skin, or just cooling it, to distract from discomfort. REDOXGold does not rely on these traditional mechanisms. Instead, it works by delivering redox signaling molecules directly to the skin. These molecules are naturally produced by the human body and play a critical role in cellular communication. This intercellular communication is important. Over time, our natural production of these molecules declines. What REDOXGold does is provide an added boost of these redox signalling molecules to the skin to support the body's ability to restore communication pathways, so it can respond more efficiently to physical exertion. We also included real, elemental gold in the formula. This is not just a product to make you feel better for an hour. It helps promote recovery where it actually starts—inside the cell. Q: Redox signaling sounds technical. How can consumers understand its real-life relevance to wellness and performance? Hunter Dean: Redox signaling is a basic process, even though the term may seem complex. It is how cells coordinate action to maintain resilience against environmental stress. Imagine a construction site without any communication between workers. Nothing would happen efficiently, and there would be chaos. That is what happens when redox signaling breaks down in the body. Muscles stay inflamed longer, recovery slows, and the effects of stress accumulate. REDOXGold supplies these molecules topically to the skin, reinforcing the body's own levels of redox signalling molecules. It is a very targeted and biological solution that respects how the body operates. That is what makes it different from chemically based products that simply override symptoms. Built for Real-World Use Q: ASEA is known for ingestible products like the REDOX Cell Signaling Supplement. Why develop a topical gel for this particular release? Hunter Dean: We wanted to give people a tool that fits into their everyday routines with minimal friction. A topical gel allows users to apply it precisely where they feel discomfort—whether that is a tired lower back, tight calves after a run, or shoulders after a long workday. There is an immediacy in applying something directly to the affected area, and that is what people are often looking for. At the same time, we knew that many consumers want a product that feels clean—no sticky residue, no heavy chemical scent, no artificial coloring. REDOXGold delivers all that. It absorbs quickly, does not stain clothes, and feels comfortable on the skin. We designed it for people who live active lives and want support that works with their natural rhythms and routines. It is not just a product for elite athletes. It is for anyone who values mobility and wants to feel physically capable. Q: Who is the intended user? Are you primarily targeting athletes, or is this for a broader group? Hunter Dean:While athletes have naturally gravitated toward REDOXGold, we created it for a much wider audience. We often refer to "Taylor," a profile that represents many of our consumers. Taylor might be someone who exercises regularly, hikes on weekends, or simply wants to feel less tension after a long day at work. Taylor prefers natural ingredients, reads labels, and avoids harsh treatments when possible. For this person, REDOXGold becomes a trusted solution. Older adults are also turning to it because they want to maintain their lifestyle and avoid feeling limited by temporary soreness. So whether someone is doing yoga, chasing after grandchildren, or preparing for a marathon, the product supports them in staying active without compromising their values or routine. Global Reach and Long-Term Vision Q: The product launched in February 2025. How has it performed internationally in such a short time? Hunter Dean: The reception has been incredibly positive, and the pace of adoption has exceeded our expectations. We launched initially in North America and Australasia—markets like the United States, Canada, Mexico, Australia, and New Zealand. By March, we expanded into 30 more countries, including major European markets such as France, Germany, Sweden, and the United Kingdom. This rapid growth was made possible by a multi-channel strategy. Our global network of independent associates played a key role in introducing the product to communities, while digital platforms helped drive awareness and online sales. We also focused on accessibility. Sample tubes allowed people to try the product before committing to full-size units, which helped generate interest and user feedback very early on. Q: What kind of feedback have you received from users? Hunter Dean: Users are telling us they experience quicker recovery after regular physical activity. We hear stories from people who had difficulty completing their daily walks or fitness routines and are now doing so with greater ease. Some older customers have shared that feel empowered and are more confident. That kind of feedback affirms what we learned prior to REDOXGold's launch with our global research university partners. It tells us that the science is not only sound, but meaningful to the people using it. That is ultimately what we care about—whether it is making a real difference in someone's quality of life. Q: Does REDOXGold signal the beginning of a broader product expansion using redox technology? Hunter Dean: Yes, it certainly does. REDOXGold is an important step forward, but it is far from the end of our work. We are continuing to explore new ways to apply redox principles across various formats. Some of these will be topical like REDOXGold, while others will be ingestible or possibly even delivered through emerging technologies. At the same time, we are refining our existing offerings based on the latest research and consumer insights. Everything we do is grounded in our long-term vision—helping people live fuller, more active lives through cellular health. We are not just adding products for the sake of variety. Each one must meet a real need and stay aligned with the science that defines ASEA. REDOXGold signals a practical shift in how people recover from physical exertion. Rather than offering a surface-level fix, it supports the body's natural repair systems at the source. As Hunter Dean puts it, "This is not about masking sensations—it is about helping the body do what it is already capable of, more efficiently and with less limitation." Explore more at:

From Research to Real Life: Transforming the Opportunity for Early Detection of Alzheimer's Disease with i-Function
From Research to Real Life: Transforming the Opportunity for Early Detection of Alzheimer's Disease with i-Function

Int'l Business Times

time24-06-2025

  • Int'l Business Times

From Research to Real Life: Transforming the Opportunity for Early Detection of Alzheimer's Disease with i-Function

When healthcare entrepreneur Peter Kallestrup co-founded i-Function®, he set out with a clear mission: to take powerful innovations confined to academic research and make them widely accessible tools for real-world cognitive health improvements. "What if we could leverage all that incredible research being done in universities and make it available so that it can benefit people in the real world?" Kallestrup asked. That question became the foundation of a company designed not just to innovate, but to democratize access to cognitive care. i-Function ® is led by Kallestrup alongside two highly regarded academics, Dr. Philip D. Harvey , an expert in mental health and cognition, and Dr. Sarah J. Czaja , a leading authority in functional skills and aging research. Together, they have played a significant role in developing two flagship products: LASSI-D® and FUNSAT®. The former is a digital cognitive assessment tool; the latter, a digital functional skills assessment and training platform. While both serve different purposes, they both play a role in the process of assessing and supporting cognitive health. LASSI-D ™ is the company's most recent innovation, a 15-minute digital cognitive assessment designed to detect the earliest stages of Mild Cognitive Impairment (MCI) and asymptomatic older adults with preclinical Alzheimer's disease. Dr. Sara J. Czaja explains, "It's like a Cardiac Stress Test for the brain. In just 15 minutes, we can tell with high probability whether your cognitive aging is likely normal or whether something else might be going on." The test is completely self-guided, with a human avatar serving the role of a human testing technician, leading users through the process privately and comfortably on most smart devices. The value of early detection can't be overstated. According to research published in The Lancet , up to 40% of the risk of developing Alzheimer's can be mitigated through mid-late life lifestyle changes if the warning signs are caught early. "What would it be worth to have two more years with your mom, dad, or spouse with normal cognitive and functional abilities?" Dr. Harvey asks. "It's priceless. That's what we aim to offer, more time, more clarity, more hope." FUNSAT ™, the company's original product, addresses functional skills: the day-to-day tasks that many with cognitive impairments struggle to perform. From managing medications to using online banking or navigating a phone voice menu, the tool helps individuals regain or build these critical capabilities. "It's not just about remembering or understanding something, it's about utilizing those cognitive skills in real life," says Dr. Harvey. "If we identify someone with early MCI using LASSI-D™, then FUNSAT™ becomes one of the suggested practical next steps in helping people live independently for longer." While i-Function's tools have applications across many domains, clinical research, mental health treatment, rehabilitation, and aging care, their business model is currently B2B. Memory clinics, assisted living facilities, concierge medical practices, state mental health organizations, and pharma are among their key clients. "We are solving two problems," Kallestrup explains. "First, we give providers a fast, affordable, documented way to screen for early cognitive issues. Second, we offer an actionable path forward. That combination is rare." The company has already seen early traction. FUNSAT™ is being used in several state-run mental health facilities and in clinical trials, and LASSI-D™ has entered its first wave of clinical adoption. The rollout is ongoing, with strong interest from both specialists and academic research centers alike. "Doctors don't always have time or the appropriate tools to assess cognitive health thoroughly or early enough, and many aren't necessarily comfortable making this assessment independently," Kallestrup notes. "With LASSI-D, they can run a fast, highly accurate screening with instant results and recommendations while patients wait. That's powerful." Importantly, i-Function® is not focused on elite clinics or high-income users. "We are not building expensive tools for the wealthy," Peter Kallestrup, CEO of i-Function®, emphasizes. "This needs to be accessible to millions. Affordability is core to our mission." This ethos is one reason i-Function® in-licenses tools from leading research universities, then develops them into scalable, tech-enabled platforms. It's not about reinventing the science, it's about amplifying it. That model has also gathered serious attention. The company's research has been supported by several highly competitive NIH grants. "Everything we do is backed by peer-reviewed science," Kallestrup says. "We have had the privilege of presenting on national stages, and last year we were cited in the National Institute of Aging annual report. But the most important recognition is seeing how our tools can change lives." Looking ahead, i-Function® plans to continue to develop its current solutions as well as broaden its portfolio with new tools focused on the broad domain of cognitive health. The goal remains consistent: find transformative but underutilized academic discoveries and bring them to the people who need them most. For Kallestrup, it's a matter of urgency as much as innovation. "If you knew you were at risk of Alzheimer's, wouldn't you want to act now? Wouldn't you want the chance to intervene while it still matters?" he says. "That's the opportunity we are giving people. And we are just getting started."

Passion, Plants, and Phase III: Devonian Health Group Is on a Mission to Disrupt Inflammation Therapy
Passion, Plants, and Phase III: Devonian Health Group Is on a Mission to Disrupt Inflammation Therapy

Int'l Business Times

time18-06-2025

  • Int'l Business Times

Passion, Plants, and Phase III: Devonian Health Group Is on a Mission to Disrupt Inflammation Therapy

While the industry might be dominated by synthetic compounds, billion-dollar VC funds, and long, uncertain development timelines, Devonian Health Group Inc. is proving there is another way. As a publicly traded company, under the leadership of its founder and CEO, Dr. André P. Boulet, Devonian has quietly advanced multi-target drug candidates and a cutting-edge cosmeceutical line, backed not by institutional investors but by a network of Canadian family offices made up of dentists, physicians, engineers, and entrepreneurs. Boulet's journey to this unconventional success story reads like a masterclass in risk, reinvention, and scientific conviction. "I'm a venture capitalist in my heart," Boulet says. "But I'm also a scientist. When I saw the anti-inflammatory results of this botanical extract technology from a university agriculture project, I knew this had real potential. So, I followed my instinct and took the risk." With a PhD in physiology-endocrinology, postdoctoral training in biochemistry and biophysics, and experience leading cardiovascular clinical research programs, Boulet's transition from academia to venture capital was swift. After climbing the pharmaceutical ladder and managing funds in Montreal, he exited his partnership and launched what would become Devonian Health Group in 2015. At its core, Devonian is a clinical-stage pharmaceutical company focused on autoimmune and inflammatory conditions, with its lead drug candidate, Thykamine ™, poised to enter Phase III clinical trials for atopic dermatitis and soon pediatric eczema. "Traditional pharma was built on the 'silver bullet,' one target, one mechanism," Boulet explains. "But now science is evolving. We're moving toward therapies that modulate multiple pathways. That's exactly what Thykamine does without shutting down important immune functions like TNF-alpha. That's why our efficacy is high, but side effects are minimal." What sets Devonian apart isn't just its marquee drug but the platform behind it. The company's patented SUPREX™ technology allows for water-based extraction, purification, and stabilization of Active Botanical Ingredients (ABIs) from plants and algae. These complexes modulate inflammation at the genetic level across multiple diseases, offering a broad pipeline of possibilities. To date, Thykamine™ has demonstrated strong results in its Phase II trial. Both gastrointestinal (ulcerative colitis) and dermatological (eczema) models have shown significant symptom relief and safety comparable to placebo. Remarkably, all this has been achieved without traditional VC backing. Boulet credits this to his deep network of entrepreneurial allies and his belief in business-first partnerships. "We've raised funds to advance to Phase III, built an extraction and production facility, and kept the company debt-free," he says. While the pharmaceutical arm garners headlines, Devonian's cosmeceutical division is equally ambitious. Operating under the Purgenesis™ brand, the company has developed a premium line of anti-aging creams containing its patented botanical ingredient R-Spinasome®, a photosynthetic cell extract with dynamic antioxidant properties. What makes Purgenesis™ unusual in the beauty space is its clinical rigor. Devonian has conducted peer-reviewed, pharma-grade clinical trials on the entire product line, something virtually unheard of in the cosmeceutical industry. "We've scientifically proven a reduction in wrinkles," says Boulet. "Not just pretty pictures, but peer-reviewed, published data. We're the only ones doing cosmeceuticals the pharma way." With day, night, and eye creams already developed and a professional-grade serum in the pipeline, Devonian is currently seeking commercial partners to bring Purgenesis™ to a global market hungry for results-backed skincare. Perhaps the most unusual aspect of Devonian's success is how personal it all feels. There are no Silicon Valley investors or hedge fund suits behind the curtain, just a network of entrepreneurs who believe in the mission. "Working with family offices is stimulating," Boulet says. "You get input from pharmacists, dentists, and industrialists. We face challenges together, and we have fun doing it." The company's headquarters in Québec includes a full-scale extraction and production facility, providing complete traceability from seed to pill. This vertical integration helps with both cutting costs, yes, but also ensuring product consistency. For Boulet, the journey has been one of passion and perseverance. "In life, there's always a risk," he reflects. "But if you surround yourself with the right people and believe in what you're building, that risk becomes your fuel. That's what Devonian is about: science, instinct, and community." As the company readies for Phase III trials in both pharmaceuticals and final-stage commercialization of its skincare line, Devonian Health Group stands as a testament to the power of conviction and the potential of plants to reshape the future of medicine.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store